Evidence suggests that the size of weight loss matters
The STEP 1 trial, published in the New England Journal of Medicine in 2021, showed that participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
7 This study introduced the concept of neutrophils undergoing aggregate reprogramming within the tumor, providing a better explanation for neutrophil plasticity in tumors
Obesity-associated Regulatory Hormones Hormones that control hunger, satiety, obesity, glucose, and maintain weight include leptin, ghrelin, cholecystokinin (CCK), oxyntomodulin (OXM), glucagon-like receptor-1 (GLP-1), insulin-like peptide-5 (INSLP-5), and peptide YY (PYY)
PlexusDx accepts HSA and FSA funds, reducing effective out-of-pocket costs for eligible patients
The risk of developing type 2 diabetes increases exponentially